| ||||
Public Act 100-0804 | ||||
| ||||
| ||||
AN ACT concerning regulation.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The Pharmacy Practice Act is amended by changing | ||||
Section 3 as follows:
| ||||
(225 ILCS 85/3)
| ||||
(Section scheduled to be repealed on January 1, 2020)
| ||||
Sec. 3. Definitions. For the purpose of this Act, except | ||||
where otherwise
limited therein:
| ||||
(a) "Pharmacy" or "drugstore" means and includes every | ||||
store, shop,
pharmacy department, or other place where | ||||
pharmacist
care is
provided
by a pharmacist (1) where drugs, | ||||
medicines, or poisons are
dispensed, sold or
offered for sale | ||||
at retail, or displayed for sale at retail; or
(2)
where
| ||||
prescriptions of physicians, dentists, advanced practice | ||||
registered nurses, physician assistants, veterinarians, | ||||
podiatric physicians, or
optometrists, within the limits of | ||||
their
licenses, are
compounded, filled, or dispensed; or (3) | ||||
which has upon it or
displayed within
it, or affixed to or used | ||||
in connection with it, a sign bearing the word or
words | ||||
"Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical
Care", | ||||
"Apothecary", "Drugstore",
"Medicine Store", "Prescriptions", | ||||
"Drugs", "Dispensary", "Medicines", or any word
or words of |
similar or like import, either in the English language
or any | ||
other language; or (4) where the characteristic prescription
| ||
sign (Rx) or similar design is exhibited; or (5) any store, or
| ||
shop,
or other place with respect to which any of the above | ||
words, objects,
signs or designs are used in any advertisement.
| ||
(b) "Drugs" means and includes (1) articles recognized
in | ||
the official United States Pharmacopoeia/National Formulary | ||
(USP/NF),
or any supplement thereto and being intended for and | ||
having for their
main use the diagnosis, cure, mitigation, | ||
treatment or prevention of
disease in man or other animals, as | ||
approved by the United States Food and
Drug Administration, but | ||
does not include devices or their components, parts,
or | ||
accessories; and (2) all other articles intended
for and having | ||
for their main use the diagnosis, cure, mitigation,
treatment | ||
or prevention of disease in man or other animals, as approved
| ||
by the United States Food and Drug Administration, but does not | ||
include
devices or their components, parts, or accessories; and | ||
(3) articles
(other than food) having for their main use and | ||
intended
to affect the structure or any function of the body of | ||
man or other
animals; and (4) articles having for their main | ||
use and intended
for use as a component or any articles | ||
specified in clause (1), (2)
or (3); but does not include | ||
devices or their components, parts or
accessories.
| ||
(c) "Medicines" means and includes all drugs intended for
| ||
human or veterinary use approved by the United States Food and | ||
Drug
Administration.
|
(d) "Practice of pharmacy" means: | ||
(1) the interpretation and the provision of assistance | ||
in the monitoring, evaluation, and implementation of | ||
prescription drug orders; | ||
(2) the dispensing of prescription drug orders; | ||
(3) participation in drug and device selection; | ||
(4) drug administration limited to the administration | ||
of oral, topical, injectable, and inhalation as follows: | ||
(A) in the context of patient education on the | ||
proper use or delivery of medications; | ||
(B) vaccination of patients 14 years of age and | ||
older pursuant to a valid prescription or standing | ||
order, by a physician licensed to practice medicine in | ||
all its branches, upon completion of appropriate | ||
training, including how to address contraindications | ||
and adverse reactions set forth by rule, with | ||
notification to the patient's physician and | ||
appropriate record retention, or pursuant to hospital | ||
pharmacy and therapeutics committee policies and | ||
procedures; and | ||
(C) administration of injections of | ||
alpha-hydroxyprogesterone caproate, pursuant to a | ||
valid prescription, by a physician licensed to | ||
practice medicine in all its branches, upon completion | ||
of appropriate training, including how to address | ||
contraindications and adverse reactions set forth by |
rule, with notification to the patient's physician and | ||
appropriate record retention, or pursuant to hospital | ||
pharmacy and therapeutics committee policies and | ||
procedures; | ||
(5) vaccination of patients ages 10 through 13 limited | ||
to the Influenza (inactivated influenza vaccine and live | ||
attenuated influenza intranasal vaccine) and Tdap (defined | ||
as tetanus, diphtheria, acellular pertussis) vaccines, | ||
pursuant to a valid prescription or standing order, by a | ||
physician licensed to practice medicine in all its | ||
branches, upon completion of appropriate training, | ||
including how to address contraindications and adverse | ||
reactions set forth by rule, with notification to the | ||
patient's physician and appropriate record retention, or | ||
pursuant to hospital pharmacy and therapeutics committee | ||
policies and procedures; | ||
(6) drug regimen review; | ||
(7) drug or drug-related research; | ||
(8) the provision of patient counseling; | ||
(9) the practice of telepharmacy; | ||
(10) the provision of those acts or services necessary | ||
to provide pharmacist care; | ||
(11) medication therapy management; and | ||
(12) the responsibility for compounding and labeling | ||
of drugs and devices (except labeling by a manufacturer, | ||
repackager, or distributor of non-prescription drugs and |
commercially packaged legend drugs and devices), proper | ||
and safe storage of drugs and devices, and maintenance of | ||
required records. | ||
A pharmacist who performs any of the acts defined as the | ||
practice of pharmacy in this State must be actively licensed as | ||
a pharmacist under this Act.
| ||
(e) "Prescription" means and includes any written, oral, | ||
facsimile, or
electronically transmitted order for drugs
or | ||
medical devices, issued by a physician licensed to practice | ||
medicine in
all its branches, dentist, veterinarian, podiatric | ||
physician, or
optometrist, within the
limits of his or her | ||
license their licenses , by a physician assistant in accordance | ||
with
subsection (f) of Section 4, or by an advanced practice | ||
registered nurse in
accordance with subsection (g) of Section | ||
4, containing the
following: (1) name
of the patient; (2) date | ||
when prescription was issued; (3) name
and strength of drug or | ||
description of the medical device prescribed;
and (4) quantity; | ||
(5) directions for use; (6) prescriber's name,
address,
and | ||
signature; and (7) DEA registration number where required, for | ||
controlled
substances.
The prescription may, but is not | ||
required to, list the illness, disease, or condition for which | ||
the drug or device is being prescribed. DEA registration | ||
numbers shall not be required on inpatient drug orders. A | ||
prescription for medication other than controlled substances | ||
shall be valid for up to 15 months from the date issued for the | ||
purpose of refills, unless the prescription states otherwise.
|
(f) "Person" means and includes a natural person, | ||
partnership,
association, corporation, government entity, or | ||
any other legal
entity.
| ||
(g) "Department" means the Department of Financial and
| ||
Professional Regulation.
| ||
(h) "Board of Pharmacy" or "Board" means the State Board
of | ||
Pharmacy of the Department of Financial and Professional | ||
Regulation.
| ||
(i) "Secretary"
means the Secretary
of Financial and | ||
Professional Regulation.
| ||
(j) "Drug product selection" means the interchange for a
| ||
prescribed pharmaceutical product in accordance with Section | ||
25 of
this Act and Section 3.14 of the Illinois Food, Drug and | ||
Cosmetic Act.
| ||
(k) "Inpatient drug order" means an order issued by an | ||
authorized
prescriber for a resident or patient of a facility | ||
licensed under the
Nursing Home Care Act, the ID/DD Community | ||
Care Act, the MC/DD Act, the Specialized Mental Health | ||
Rehabilitation Act of 2013, the Hospital Licensing Act, or the | ||
University of Illinois Hospital Act "An Act in relation to
the | ||
founding and operation of the University of Illinois Hospital | ||
and the
conduct of University of Illinois health care | ||
programs", approved July 3, 1931,
as amended , or a facility | ||
which is operated by the Department of Human
Services (as | ||
successor to the Department of Mental Health
and Developmental | ||
Disabilities) or the Department of Corrections.
|
(k-5) "Pharmacist" means an individual health care | ||
professional and
provider currently licensed by this State to | ||
engage in the practice of
pharmacy.
| ||
(l) "Pharmacist in charge" means the licensed pharmacist | ||
whose name appears
on a pharmacy license and who is responsible | ||
for all aspects of the
operation related to the practice of | ||
pharmacy.
| ||
(m) "Dispense" or "dispensing" means the interpretation, | ||
evaluation, and implementation of a prescription drug order, | ||
including the preparation and delivery of a drug or device to a | ||
patient or patient's agent in a suitable container | ||
appropriately labeled for subsequent administration to or use | ||
by a patient in accordance with applicable State and federal | ||
laws and regulations.
"Dispense" or "dispensing" does not mean | ||
the physical delivery to a patient or a
patient's | ||
representative in a home or institution by a designee of a | ||
pharmacist
or by common carrier. "Dispense" or "dispensing" | ||
also does not mean the physical delivery
of a drug or medical | ||
device to a patient or patient's representative by a
| ||
pharmacist's designee within a pharmacy or drugstore while the | ||
pharmacist is
on duty and the pharmacy is open.
| ||
(n) "Nonresident pharmacy"
means a pharmacy that is located | ||
in a state, commonwealth, or territory
of the United States, | ||
other than Illinois, that delivers, dispenses, or
distributes, | ||
through the United States Postal Service, commercially | ||
acceptable parcel delivery service, or other common
carrier, to |
Illinois residents, any substance which requires a | ||
prescription.
| ||
(o) "Compounding" means the preparation and mixing of | ||
components, excluding flavorings, (1) as the result of a | ||
prescriber's prescription drug order or initiative based on the | ||
prescriber-patient-pharmacist relationship in the course of | ||
professional practice or (2) for the purpose of, or incident | ||
to, research, teaching, or chemical analysis and not for sale | ||
or dispensing. "Compounding" includes the preparation of drugs | ||
or devices in anticipation of receiving prescription drug | ||
orders based on routine, regularly observed dispensing | ||
patterns. Commercially available products may be compounded | ||
for dispensing to individual patients only if all of the | ||
following conditions are met: (i) the commercial product is not | ||
reasonably available from normal distribution channels in a | ||
timely manner to meet the patient's needs and (ii) the | ||
prescribing practitioner has requested that the drug be | ||
compounded.
| ||
(p) (Blank).
| ||
(q) (Blank).
| ||
(r) "Patient counseling" means the communication between a | ||
pharmacist or a student pharmacist under the supervision of a | ||
pharmacist and a patient or the patient's representative about | ||
the patient's medication or device for the purpose of | ||
optimizing proper use of prescription medications or devices. | ||
"Patient counseling" may include without limitation (1) |
obtaining a medication history; (2) acquiring a patient's | ||
allergies and health conditions; (3) facilitation of the | ||
patient's understanding of the intended use of the medication; | ||
(4) proper directions for use; (5) significant potential | ||
adverse events; (6) potential food-drug interactions; and (7) | ||
the need to be compliant with the medication therapy. A | ||
pharmacy technician may only participate in the following | ||
aspects of patient counseling under the supervision of a | ||
pharmacist: (1) obtaining medication history; (2) providing | ||
the offer for counseling by a pharmacist or student pharmacist; | ||
and (3) acquiring a patient's allergies and health conditions.
| ||
(s) "Patient profiles" or "patient drug therapy record" | ||
means the
obtaining, recording, and maintenance of patient | ||
prescription
information, including prescriptions for | ||
controlled substances, and
personal information.
| ||
(t) (Blank).
| ||
(u) "Medical device" or "device" means an instrument, | ||
apparatus, implement, machine,
contrivance, implant, in vitro | ||
reagent, or other similar or related article,
including any | ||
component part or accessory, required under federal law to
bear | ||
the label "Caution: Federal law requires dispensing by or on | ||
the order
of a physician". A seller of goods and services who, | ||
only for the purpose of
retail sales, compounds, sells, rents, | ||
or leases medical devices shall not,
by reasons thereof, be | ||
required to be a licensed pharmacy.
| ||
(v) "Unique identifier" means an electronic signature, |
handwritten
signature or initials, thumb print, or other | ||
acceptable biometric
or electronic identification process as | ||
approved by the Department.
| ||
(w) "Current usual and customary retail price" means the | ||
price that a pharmacy charges to a non-third-party payor.
| ||
(x) "Automated pharmacy system" means a mechanical system | ||
located within the confines of the pharmacy or remote location | ||
that performs operations or activities, other than compounding | ||
or administration, relative to storage, packaging, dispensing, | ||
or distribution of medication, and which collects, controls, | ||
and maintains all transaction information. | ||
(y) "Drug regimen review" means and includes the evaluation | ||
of prescription drug orders and patient records for (1)
known | ||
allergies; (2) drug or potential therapy contraindications;
| ||
(3) reasonable dose, duration of use, and route of | ||
administration, taking into consideration factors such as age, | ||
gender, and contraindications; (4) reasonable directions for | ||
use; (5) potential or actual adverse drug reactions; (6) | ||
drug-drug interactions; (7) drug-food interactions; (8) | ||
drug-disease contraindications; (9) therapeutic duplication; | ||
(10) patient laboratory values when authorized and available; | ||
(11) proper utilization (including over or under utilization) | ||
and optimum therapeutic outcomes; and (12) abuse and misuse.
| ||
(z) "Electronically transmitted prescription" means a | ||
prescription that is created, recorded, or stored by electronic | ||
means; issued and validated with an electronic signature; and |
transmitted by electronic means directly from the prescriber to | ||
a pharmacy. An electronic prescription is not an image of a | ||
physical prescription that is transferred by electronic means | ||
from computer to computer, facsimile to facsimile, or facsimile | ||
to computer.
| ||
(aa) "Medication therapy management services" means a | ||
distinct service or group of services offered by licensed | ||
pharmacists, physicians licensed to practice medicine in all | ||
its branches, advanced practice registered nurses authorized | ||
in a written agreement with a physician licensed to practice | ||
medicine in all its branches, or physician assistants | ||
authorized in guidelines by a supervising physician that | ||
optimize therapeutic outcomes for individual patients through | ||
improved medication use. In a retail or other non-hospital | ||
pharmacy, medication therapy management services shall consist | ||
of the evaluation of prescription drug orders and patient | ||
medication records to resolve conflicts with the following: | ||
(1) known allergies; | ||
(2) drug or potential therapy contraindications; | ||
(3) reasonable dose, duration of use, and route of | ||
administration, taking into consideration factors such as | ||
age, gender, and contraindications; | ||
(4) reasonable directions for use; | ||
(5) potential or actual adverse drug reactions; | ||
(6) drug-drug interactions; | ||
(7) drug-food interactions; |
(8) drug-disease contraindications; | ||
(9) identification of therapeutic duplication; | ||
(10) patient laboratory values when authorized and | ||
available; | ||
(11) proper utilization (including over or under | ||
utilization) and optimum therapeutic outcomes; and | ||
(12) drug abuse and misuse. | ||
"Medication therapy management services" includes the | ||
following: | ||
(1) documenting the services delivered and | ||
communicating the information provided to patients' | ||
prescribers within an appropriate time frame, not to exceed | ||
48 hours; | ||
(2) providing patient counseling designed to enhance a | ||
patient's understanding and the appropriate use of his or | ||
her medications; and | ||
(3) providing information, support services, and | ||
resources designed to enhance a patient's adherence with | ||
his or her prescribed therapeutic regimens. | ||
"Medication therapy management services" may also include | ||
patient care functions authorized by a physician licensed to | ||
practice medicine in all its branches for his or her identified | ||
patient or groups of patients under specified conditions or | ||
limitations in a standing order from the physician. | ||
"Medication therapy management services" in a licensed | ||
hospital may also include the following: |
(1) reviewing assessments of the patient's health | ||
status; and | ||
(2) following protocols of a hospital pharmacy and | ||
therapeutics committee with respect to the fulfillment of | ||
medication orders.
| ||
(bb) "Pharmacist care" means the provision by a pharmacist | ||
of medication therapy management services, with or without the | ||
dispensing of drugs or devices, intended to achieve outcomes | ||
that improve patient health, quality of life, and comfort and | ||
enhance patient safety.
| ||
(cc) "Protected health information" means individually | ||
identifiable health information that, except as otherwise | ||
provided, is:
| ||
(1) transmitted by electronic media; | ||
(2) maintained in any medium set forth in the | ||
definition of "electronic media" in the federal Health | ||
Insurance Portability and Accountability Act; or | ||
(3) transmitted or maintained in any other form or | ||
medium. | ||
"Protected health information" does not include | ||
individually identifiable health information found in: | ||
(1) education records covered by the federal Family | ||
Educational Right and Privacy Act; or | ||
(2) employment records held by a licensee in its role | ||
as an employer. | ||
(dd) "Standing order" means a specific order for a patient |
or group of patients issued by a physician licensed to practice | ||
medicine in all its branches in Illinois. | ||
(ee) "Address of record" means the designated address | ||
recorded by the Department in the applicant's application file | ||
or licensee's license file maintained by the Department's | ||
licensure maintenance unit. | ||
(ff) "Home pharmacy" means the location of a pharmacy's | ||
primary operations.
| ||
(gg) "Email address of record" means the designated email | ||
address recorded by the Department in the applicant's | ||
application file or the licensee's license file, as maintained | ||
by the Department's licensure maintenance unit. | ||
(Source: P.A. 99-180, eff. 7-29-15; 100-208, eff. 1-1-18; | ||
100-497, eff. 9-8-17; 100-513, eff. 1-1-18; revised 9-29-17.) | ||
Section 10. The Illinois Food, Drug and Cosmetic Act is | ||
amended by changing Section 2.36 as follows:
| ||
(410 ILCS 620/2.36) (from Ch. 56 1/2, par. 502.36)
| ||
Sec. 2.36.
"Prescription" means and includes any order for | ||
drugs or
medical devices, written, facsimile, or verbal by a | ||
physician licensed
to
practice medicine in all its branches, | ||
dentist, veterinarian,
or podiatric physician containing the | ||
following: (1) name of the
patient; (2) date when prescription | ||
was given; (3) name and strength of
drug or description of the | ||
medical device prescribed; (4) quantity, (5)
directions
for |
use, (6) prescriber's name, address and signature, and (7) DEA
| ||
number where
required, for controlled substances. A | ||
prescription for medication other than controlled substances | ||
shall be valid for up to 15 months from the date issued for the | ||
purpose of refills, unless the prescription states otherwise.
| ||
(Source: P.A. 98-214, eff. 8-9-13.)
|